Overview

The Effect of Thiamine vs. Placebo on VO2 in Critical Illness

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the effect of thiamine therapy on oxygen consumption (VO2) in critically-ill patients. We will evaluate this by measuring VO2 before and after thiamine or placebo administration in patients admitted to the ICU and requiring mechanical ventilation. A secondary aim is to evaluate the effect of thiamine vs. placebo on the metabolic profile of the patients.
Phase:
Phase 2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Treatments:
Thiamine